Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in acute ischemic stroke
IRCT20211017052786N7Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of memantine in ischemic stroke and brain infarction (2 arms), sponsored by Qom University of Medical Sciences. Primary endpoint: NIH Stroke Scale score. Started Nov 2025; status: completed.
02
Drugs
memantine
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on IRCT20211017052786N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211017052786N7.